2025年基本医保目录及商保创新药目录调整申报操作指南出炉 首度纳入商保创新药目录

Core Viewpoint - The National Healthcare Security Administration has released the "2025 Basic Medical Insurance Directory and Commercial Insurance Innovative Drug Directory Adjustment Application Guidelines," marking the first inclusion of the commercial health insurance innovative drug directory in the adjustment plan, indicating a significant role for commercial health insurance in the multi-tiered medical security system [1] Group 1 - The adjustment signifies an important step for market access of innovative drugs under commercial health insurance [1] - The inclusion of the commercial health insurance innovative drug directory highlights the evolving landscape of healthcare financing in China [1] - This move is expected to enhance the role of commercial health insurance in providing comprehensive medical coverage [1]